Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Management of Penetrating Aortic Ulcer

Initial Management

  • The American Heart Association recommends maintaining a heart rate ≤60 beats per minute and a systolic blood pressure <120 mmHg to reduce aortic wall stress and prevent complications in patients with penetrating aortic ulcer of the descending aorta 1
  • Initial management of penetrating aortic ulcer of the descending aorta should aim to decrease aortic wall stress by controlling heart rate and blood pressure, according to the European Society of Cardiology 1, 2

Hemodynamic Control Objectives

Heart Rate Control

  • The target heart rate is ≤60 beats per minute, and intravenous beta-blockers should be initiated and titrated to achieve this goal, as recommended by the American College of Cardiology 1
  • In patients with clear contraindications to beta-blockers, non-dihydropyridine calcium channel blockers should be used as an alternative for heart rate control, according to the American Heart Association 1

Blood Pressure Control

  • The target blood pressure is systolic <120 mmHg and diastolic <80 mmHg, as recommended by the American Heart Association 3, 4
  • After achieving adequate heart rate control, if systolic blood pressure remains >120 mmHg, intravenous angiotensin-converting enzyme inhibitors and/or other vasodilators should be administered, according to the American College of Cardiology 1
  • Uncontrolled hypertension is a known risk factor for aortic rupture and dissection, as stated by the American Heart Association 4

Important Considerations

  • The European Society of Cardiology recommends that vasodilator therapy should not be initiated before heart rate control, as it may provoke reflex tachycardia that increases aortic wall stress 1
  • In cases of type B penetrating aortic ulcer (descending aorta), initial medical therapy under close surveillance is recommended, according to the European Society of Cardiology 2
  • Repeat imaging (computed tomography or magnetic resonance imaging) should be performed to monitor the evolution of the lesion, as recommended by the European Society of Cardiology 2

Long-Term Management

  • In patients with penetrating aortic ulcer of the descending aorta, medical management includes strict long-term blood pressure control, as recommended by the European Society of Cardiology 2, 4
  • Therapy with moderate- to high-intensity statins is recommended if there is evidence of aortic atherosclerosis, according to the American Heart Association 4
  • Low-dose aspirin (75-162 mg/day) should be used to reduce the risk of cardiovascular events, as recommended by the American Heart Association 4

Indications for Intervention

  • Endovascular treatment (TEVAR) should be considered in complicated type B penetrating aortic ulcer, according to the European Society of Cardiology 2
  • Complications that justify intervention include recurrent pain, hematoma expansion, periaortic hematoma, and intimal disruption, as stated by the European Society of Cardiology 2

Penetrating Aortic Ulcer Diagnosis and Management

Definition and Characteristics

  • The American Heart Association defines a penetrating aortic ulcer (PAU) as an atherosclerotic lesion with ulceration that penetrates the internal elastic lamina, allowing the formation of a hematoma within the media of the aortic wall 5
  • PAUs typically develop in segments of the aorta where atherosclerotic changes are most common, with over 90% of cases occurring in the descending thoracic aorta 5
  • The classic appearance of the lesion is a mushroom-shaped protrusion of the aortic lumen with overhanging edges, similar to a gastric ulcer 5

Clinical Presentation

  • The typical patient with PAU is an older adult (usually over 65 years) with hypertension and diffuse atherosclerosis, presenting with chest or back pain 5
  • The clinical presentation of acute aortic syndromes can be variable and atypical, including referred abdominal pain to the right upper quadrant 6
  • The pain can be referred to different regions due to shared innervation between thoracic and abdominal structures 7
  • The extension of the intramural hematoma that can accompany PAU can also cause referred pain 5, 8

Diagnosis and Evaluation

  • It is crucial to differentiate PAU from other causes of acute aortic syndrome, such as intramural hematoma and classic aortic dissection 8, 6
  • Computed tomography (CT) with contrast is the diagnostic technique of choice, with a sensitivity of 96% for detecting associated intramural hematoma 6
  • On CT, PAU is visualized as a mushroom-shaped protrusion of the arterial lumen with outward-facing edges, while intramural hematoma appears as a crescentic or circular thickening of the arterial wall with a maximum thickness of 7 mm or greater 6
  • Transesophageal echocardiography (TEE) can be useful for visualizing PAU, showing atherosclerotic plaques that protrude into the aortic lumen 8

Complications and Evolution

  • PAU can evolve into intramural hematoma formation 5, 8
  • PAU can also lead to aortic dissection 5, 6
  • The pain in the right upper quadrant could indicate extension of the inflammatory process 9
  • Compromise of visceral branches can also occur, leading to referred pain 10

Management and Follow-up

  • The American College of Radiology recommends surveillance with CT or magnetic resonance imaging to evaluate disease progression 10
  • The management of PAU depends on the location, extent, and associated complications 6
  • Endovascular repair should be considered for penetrating ulcers with intramural hematoma if there is persistent pain, expansion of the hematoma, signs of distal ischemia, or risk of rupture 6

Progression of Ulcerated Plaque to Penetrating Aortic Ulcer

Pathophysiology of Progression

  • PAU is characterized by localized ulceration of an aortic atherosclerotic plaque that penetrates through the internal elastic lamina into the media, frequently associated with intramural hematoma (IMH) and diffuse atherosclerosis 11

Risk Factors for Progression

  • Most patients with PAU are older males (typically >65 years), smokers, with multiple comorbidities including systemic hypertension, coronary artery disease, COPD, renal insufficiency, and concurrent abdominal aneurysm 11

Complications of Progression

  • When a PAU develops, especially when complicated with IMH, the risk of rupture can be as high as 33%-75%, and progression to dissection is associated with high mortality 11

Diagnostic Considerations

  • Computed tomography (CT) is the diagnostic technique of choice for detecting PAU and monitoring progression 11

Management Implications

  • Symptom onset may indicate PAU expansion (tunica adventitia involvement); thus, urgent imaging and appropriate therapeutic intervention are needed to prevent aortic rupture 11
  • For uncomplicated type B PAU (descending aorta), initial medical therapy under careful surveillance is recommended 12
  • High-risk imaging features that suggest progression and may warrant intervention include:
    • Maximum PAU width ≥13-20 mm 13
    • Maximum PAU depth ≥10 mm 13
    • Significant growth of PAU width or depth >5 mm/year 13
    • PAU associated with a saccular aneurysm 13
    • PAU with an increasing pleural effusion 13

Clinical Pitfalls to Avoid

  • Asymptomatic PAUs are often diagnosed as incidental findings during imaging examinations, but should not be ignored as they can still progress to serious complications 11

Management of Aortic Penetrating Ulcers

Initial Medical Management

  • The European Heart Journal recommends immediate medical therapy with aggressive blood pressure and heart rate control for all patients with penetrating aortic ulcers (PAU), with management strategy determined by anatomic location and presence of complications 14, 15
  • Medical therapy including pain relief and blood pressure control is mandatory in all patients with PAU regardless of location or severity, according to the European Heart Journal 14, 15, 16

Type A PAU (Ascending Aorta)

  • Surgery is recommended for all Type A PAU, as stated by the European Heart Journal 14, 15, 16
  • The European Heart Journal suggests that in highly selected patients with increased operative risk and uncomplicated Type A PAU without high-risk imaging features, a "wait-and-see" strategy may be considered 14, 15

Type B PAU (Descending Thoracic Aorta)

  • Initial medical therapy under careful surveillance is recommended for all Type B PAU, according to the European Heart Journal 14, 15, 16
  • The European Heart Journal recommends repetitive imaging (CMR, CCT, or TOE) for uncomplicated Type B PAU 14, 15, 16
  • Follow-up imaging at 1 month after diagnosis, then every 6 months if imaging findings are stable, is recommended for uncomplicated Type B PAU, as stated by the European Heart Journal 17, 16

Lipid Management

  • The European Heart Journal recommends LDL-C reduction by ≥50% from baseline with goal <1.4 mmol/L (<55 mg/dL) for patients with aortic atherosclerosis 18

Diagnostic Imaging

  • The European Heart Journal states that cardiovascular computed tomography (CCT) represents the technique of choice for diagnosis of PAU 14, 15
  • TOE and CMR are valid alternatives based on availability and local expertise, according to the European Heart Journal 14, 15

Patient Demographics and Risk Factors

  • The European Heart Journal notes that PAU typically affects older males (>65 years), smokers, with multiple comorbidities including systemic hypertension, coronary artery disease, COPD, renal insufficiency, and concurrent abdominal aneurysm 15
  • Symptom onset may indicate PAU expansion involving the tunica adventitia, requiring urgent imaging and therapeutic intervention to prevent aortic rupture, as stated by the European Heart Journal 15

Management Guidelines for Penetrating Aortic Ulcers

Initial Medical Management

  • The European Society of Cardiology recommends immediate medical therapy with aggressive blood pressure control (systolic <120 mmHg) and heart rate control (≤60 bpm) for all patients with penetrating aortic ulcers (PAU), with subsequent management determined by anatomic location and presence of complications 19, 20
  • Medical therapy is mandatory for all patients regardless of PAU location or severity, according to the European Heart Journal 19, 20, 21
  • Adequate analgesia is essential as part of initial management for patients with PAU 19, 20, 21

Diagnostic Imaging

  • Contrast-enhanced computed tomography (CCT) is the diagnostic technique of choice with 96% sensitivity for detecting associated intramural hematoma, as recommended by the European Heart Journal 19, 22
  • Alternative imaging modalities such as transoesophageal echocardiography (TOE) or cardiac magnetic resonance (CMR) may be used based on availability and local expertise 19, 20, 22
  • 18FDG-PET-CT can detect increased metabolic activity in PAUs, according to the European Heart Journal 19, 20

Management by Anatomic Location

  • Surgery is recommended for all Type A PAU, according to the European Heart Journal 19, 20, 21, 23
  • Initial medical therapy under careful surveillance is recommended for all Type B PAU, as stated by the European Heart Journal 19, 20, 21, 23
  • Endovascular treatment (TEVAR) is recommended as first-line therapy for complicated Type B PAU, according to the European Heart Journal 19, 20, 21, 23

High-Risk Imaging Features Requiring Intervention

  • Any of the following features indicate high risk and warrant consideration for intervention: maximum PAU width ≥13-20 mm, maximum PAU depth ≥10 mm, significant growth of PAU width or depth >5 mm/year, PAU associated with a saccular aneurysm, PAU with increasing pleural effusion, as recommended by the European Heart Journal 19, 20, 21, 22, 24

Long-Term Medical Management

  • Continue antihypertensive therapy indefinitely for all patients with PAU, as recommended by the European Heart Journal 23, 25

Outcomes and Prognosis

  • Small asymptomatic PAUs without high-risk features may be managed conservatively with regular surveillance, according to the European Heart Journal 19, 20

REFERENCES

6

Acute Aortic Syndrome: Penetrating Ulcer in Left Common Iliac Artery with Intramural Hematoma [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

9

Pseudoaneurysm Diagnosis and Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025